What's new with glucocorticoids in severe community-acquired pneumonia?
Pierre-François Dequin1,2,3, Julio A Ramirez4,5, Grant Waterer6,7,8
1INSERM UMR 1100, Research Center for Respiratory Diseases, Tours University, Tours, France. dequin@univ-tours.fr.
No abstract available in PubMed .
More Related Videos
08:02Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
Published on: April 25, 2016
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
